Patients' Satisfaction With Chemotherapy Influences Health-Related Quality of Life in Advanced Thoracic Cancer

Dutch researchers sought to determine the association between satisfaction with treatment and HRQoL scores among patients with locally advanced or metastatic thoracic cancer receiving pemetrexed.

Healthcare Professionals Weigh In on Chemotherapy Use In Malignant Pleural Mesothelioma

A survey of healthcare professionals sought to determine their perspectives on aspects of treatment decision-making related to administration of chemotherapy in eligible patients with malignant pleural mesothelioma.

Malignant Pleural Effusion Interventions: What Matters Most to the Patient?

Patients with malignant pleural effusion may care more about relieving symptoms such as dyspnea as opposed to achieving pleurodesis.

Counseling on the Dangers of Vaping

How can nurses caring for smokers counsel patients on quitting smoking when many are using vaping as an alternative to cigarettes?

Chemoradiotherapy Outcomes Associated With Stage of Small Cell Lung Cancer

A secondary analysis of data from the CONVERT trial compared survival outcomes after chemoradiotherapy for patients with stage I-II vs patients with stage III disease.

Lung Cancer-Specific Distress Screening Tool Not Needed But Has Potential Benefit

Using focus groups, researchers evaluated patient-reported psychosocial consequences of lung cancer to determine if a lung cancer-specific distress screening instrument would benefit these patients.

Immunotherapy Side Effects May Be More Common Than Thought

Higher rates of adverse events observed for immune checkpoint inhibitors in real-world settings, compared to clinical trials.

Safe to Administer B12 Supplementation, Pemetrexed Infusions for Lung Cancers on Same Day

Mean changes in hematologic indices found similar regardless of same-day or prior administration of B12 supplementation in patients receiving pemetrexed for NSCLC or pleural mesothelioma.

Clinical Trial: Improving Management of Breathlessness in Patients With Lung Cancer

Clinical Trial: Lung Cancer Screening Study With Low-dose CT Scan and Blood Biomarker

Clinical Trial: Lung Cancer Biomarkers and Screening (NYULCBC)